Cutaneous vascularitis

Breaking Ground: Palvella Therapeutics Completes Enrollment in Phase 2 TOIVA Trial for QTORIN™ Rapamycin in Cutaneous Venous Malformations

Bree Clare - September 17, 2025
Genetic Testing

Suspect a Rare Disease? Genetic Testing Might Be the Best Course of Action

Prader-Willi Syndrome

Diagnosis and management of sleep disorders in Prader-Willi syndrome

Head and neck cancer

Advanced Head and Neck Squamous Cell Carcinoma Patients Double Survival Time

LISTEN TO OUR PODCAST

THE LATEST FROM PATIENT WORTHY

FEATURED

Finding Light Through Story – The Power of Ambassadorship in Endometrial Cancer Community

Read Full Story Here

Why Your Voice in Research Matters: Groundbreaking Studies Are Changing What’s Possible

Bridging the Diversity Gap in Healthcare

Rare Disease Clinical Trials Are Essential to Help Uncover Potential Patient Solutions: Spotlight on Classic Congenital Adrenal Hyperplasia (CAH)

UPCOMING EVENTS

SIGN UP FOR OUR NEWSLETTER

SIGN UP »

FOLLOW US ON INSTAGRAM

FOLLOW US ON TIKTOK

FOLLOW US ON FACEBOOK

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons
Patient Worthy
5 hours ago
Patient Worthy

Folic Acid Awareness Week is here! This essential B vitamin is vital for healthy pregnancies, but it benefits everyone - helping your cells, heart, and brain. Add more folic acid-rich foods to your plate and take charge of your health! #FolicAcidAwarenessWeek #folicacid #PatientWorthy ... See MoreSee Less

Folic Acid Awareness Week is here! This essential B vitamin is vital for healthy pregnancies, but it benefits everyone - helping your cells, heart, and brain. Add more folic acid-rich foods to your plate and take charge of your health! #FolicAcidAwarenessWeek #FolicAcid #PatientWorthyImage attachmentImage attachment+2Image attachment
View on Facebook
· Share
Share on Facebook Share on Twitter Share on Linked In Share by Email
View Comments
  • likes 0
  • Shares: 0
  • Comments: 0
Patient Worthy
6 hours ago
Patient Worthy

Breaking Ground: Palvella Therapeutics Completes Enrollment in Phase 2 TOIVA Trial for QTORIN™ Rapamycin in Cutaneous Venous Malformations bit.ly/3HXu7r6 Read now at PatientWorthy.com
#PatientWorthy #clinicaltrial #cutaneousvenousmalformations ... See MoreSee Less

Breaking Ground: Palvella Therapeutics Completes Enrollment in Phase 2 TOIVA Trial for QTORIN™ Rapamycin in Cutaneous Venous Malformations https://bit.ly/3HXu7r6 Read now at PatientWorthy.com #PatientWorthy #ClinicalTrial #CutaneousVenousMalformations
View on Facebook
· Share
Share on Facebook Share on Twitter Share on Linked In Share by Email
View Comments
  • likes 0
  • Shares: 0
  • Comments: 0
Patient Worthy
8 hours ago
Patient Worthy

#braintumors #glioblastoma ... See MoreSee Less

#braintumors #GlioblastomaImage attachmentImage attachment+5Image attachment
View on Facebook
· Share
Share on Facebook Share on Twitter Share on Linked In Share by Email
View Comments
  • likes 0
  • Shares: 0
  • Comments: 0
Load more
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy